1,721,284 research outputs found
Heparin dose during percutaneous coronary intervention: how low dare we go?
Despite dramatic advances in percutaneous coronary intervention, including coronary stents and potent antiplatelet agents, unfractionated heparin remains the standard procedural anticoagulant. Tradition and habit may have considerable influence over dose selection. A review of the role and dosage of heparin during PCI appears to be overdu
Extensive right coronary artery dissection following cutting balloon treatment of in-stent restenosis.
Debris trapped by a distal protection device may mimic no-reflow during percutaneous coronary intervention
Intravascular ultrasound as a significant tool for diagnosis and management of coronary aneurysms.
Management of Calcific Coronary Artery Lesions: Is it Time to Change Our Interventional Therapeutic Approach?
Patients with obstructive coronary lesions with a high calcium content (LHCC) have an exaggerated clinical risk, because the presence of calcification is associated with more extensive coronary atheroma and higher burden of comorbidities. Treatment of LHCC using percutaneous techniques is complex because of an increased risk of incomplete lesion preparation with suboptimal stent deployment and higher rates of acute and chronic stent failure. Rotational atherectomy has been the predominant technology for treatment of high-grade LHCC, but novel devices/technologies have entered clinical practice. It seems likely that combining enhanced intravascular imaging, which allows definition of the patterns of calcification with these new technologies, will herald a change in procedural algorithms for treatment of LHCC. This review provides an overview about LHCC with special focus on existing and emergent technologies. We also provide a proposed procedural algorithm to facilitate optimal use of technology according to specific features of LHCC and coronary anatomy. (C) 2019 by the American College of Cardiology Foundation
- …
